Revium Rx COO and President Inna Martin Resigns Amid 'Differences in Expectations'
RVRC has more than doubled off its 52-week low of $0.3 on light trading volume (0.3× avg).
Summary
Revium Rx's COO and President, Inna Martin, has resigned, effective June 16, with employment terminating September 10. This follows the company's CFO resignation earlier this month and a series of negative financial reports, including repeated 'going concern' warnings. The 8-K filed moments before this news cited 'differences in expectations' as the reason for Martin's departure. The departure of two key executives within a month, particularly with stated internal disagreements, signals significant leadership instability and raises further concerns for a company already facing severe financial distress.
At the time of this announcement, RVRC was trading at $1.67 on OTC in the Life Sciences sector, with a market capitalization of approximately $101.4M. The 52-week trading range was $0.30 to $50.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.